Exparel - Patient-focused

For the Management of Postsurgical Pain

EXPAREL
(bupivacaine liposome injectable suspension)

Patient-Focused Pain Control That Lasts For Up To 72 Hours

The only single-dose local analgesic to
• Reduce or eliminate opioids with pain control for up to 3 days
• Without the need for catheters or pumps

Pivotal studies have demonstrated the safety and efficacy of EXPAREL in patients undergoing bunionectomy and hemorrhoidectomy procedures.

The clinical benefit of the attendant decrease in opioid consumption was not demonstrated.

EXPAREL is a liposome formulation of bupivacaine indicated for administration into the surgical site to produce postsurgical analgesia.

EXPAREL
(bupivacaine liposome injectable suspension)

PATIENT-FOCUSED PAIN CONTROL

Pacira Pharmaceuticals

---

Campaign files

Brand name: Exparel
Country/Market: USA, North America
Target: Healthcare Professional (HCP)
Tagline: Patient-focused pain control
Medium: Print ad 
Size/duration: Single-page  
Publication/Aired: 
Bariatric Times - April 2013
Anesthesiology News - November 2013 (insert)

To see more of this brand's ads, click here